Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(5)
•••
Snowballgrowth
X
View Profile
View Bullboard History
Comment by
Snowballgrowth
on Jan 15, 2023 7:53am
RE:RE:RE:RE:RE:Repurchases so far from NCIB
Not much new info since last Q results. What do you watch until next Q ? Do we have clues about Exelon sales once they did the transition with Novartis ? GUD expertise is to market unpromoted
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 14, 2023 2:55pm
RE:RE:RE:RE:Repurchases so far from NCIB
Well done EOJ. You don't hold these shares unless you're doing it the way you did it with Paladin. Only a handful of investors here - accumulating for the long-term. What did I say ... ~60
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(138)
•••
Eoj123
X
View Profile
View Bullboard History
Comment by
Eoj123
on Jan 13, 2023 6:50pm
RE:RE:RE:Repurchases so far from NCIB
I'm sure glad I sold this about a half a dozen years ago shorly after they sold their priority review voucher and just after their run to $10. It's been a dog since
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 11, 2023 3:38pm
RE:RE:Repurchases so far from NCIB
For anyone reading this forum, these three Jokers Aliases is one person provide a sht show illusion
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on Jan 11, 2023 3:38pm
RE:RE:Repurchases so far from NCIB
Thanks for the correction on amount so far. Good to see they still could continue to reduce shares outstanding. Another 5.5 million.
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 11, 2023 3:25pm
RE:Repurchases so far from NCIB
Of the 8M shares that we can purchase, we've purchased a little over 2.5M from my calculations. It's a slower pace than last year but we're on pace for ~5M shares, which would bring us to
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jan 11, 2023 3:20pm
Repurchases so far from NCIB
- has there been more than the 450k, as recently discussed? - with total NCIB potential , when management sees favourable, they could originally Re-purchase up to almost 8,000,000 shares. - so
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 10, 2023 6:58pm
RE:RE:RE:Something to think about...
Yes they did ! Almost half a million. Filed 2023-01-10 11:59 Tx date 2022-12-21 $GUD Knight Therapeutics Inc. Knight
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 6:18pm
RE:RE:RE:Something to think about...
..and to be able do that they borrowed 32 millions dollars of worthless of monopolyLatam money paper depretiating @ 10% per months. When they can no loger borrow soon the share price will sink to $ 2
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 10, 2023 5:42pm
RE:RE:Something to think about...
That was timely! So they repurchased another 450k shares in December.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 5:07pm
RE:RE:RE:Something to think about...
Yep making money on people who are making $2 dollars a day and fighting for $5, are you dumb, deaft, blind and callus to the human tragedies takiing place in LATAM? Hundreds of
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 10, 2023 3:46pm
RE:RE:Something to think about...
Some kind of deal - even if it's small would seem logical in 2023. I know a small pharma that's getting regular requests to tie up for their heavy bank account and that's only $42 MM
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 10, 2023 3:38pm
RE:RE:Thanks Golden ...
If I were in a Rock N Roll band ... they'd surely be my groupies. Maybe even Chapman to my John Lennon. A little cringeworthy. : )
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 10, 2023 2:35pm
RE:Something to think about...
If you believe that tthe tax assessment will go our way. You can add 46M to our cash total. Making the market value of the base operations ~$250M which yields 18% cash. Separately, there
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company